Last updated 2026-06-18
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
0
Rounds' value
$2.0M
total disclosed, rounds participated
Stages
—
Portfolio · 1
Investment activity
Portfolio by sector
Business Software1
Health Tech & Life Sciences1
Q&A
- What is Excell Partners' investment focus by sector?
- Excell Partners has invested in companies within the Business Software and Health Tech & Life Sciences sectors.
- What is Excell Partners' typical investment stage?
- Excell Partners primarily invests in A Round funding stages, with two such investments recorded.
- Can you name some of Excell Partners' portfolio companies?
- Excell Partners' portfolio includes Lexifone, an automatic in-call translator, and Neurogenesis, a company focused on neurodegenerative disease cell therapy.
- When did Excell Partners make its most recent investment?
- Excell Partners made an investment in March 2022.
- What was Excell Partners' earliest recorded investment?
- Excell Partners' earliest recorded investment was in December 2011.
- What is the typical investment range for Excell Partners?
- Excell Partners' investment range is between $2M and $6.66M.
- Which company in Excell Partners' portfolio operates in the Health Tech & Life Sciences sector?
- Neurogenesis, a company focused on neurodegenerative disease cell therapy, is a portfolio company of Excell Partners in the Health Tech & Life Sciences sector.
- Which company in Excell Partners' portfolio operates in the Business Software sector?
- Lexifone, an automatic in-call translator, is a portfolio company of Excell Partners in the Business Software sector.